CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

PGIM India Healthcare Fund-Reg(G)

very highequitypharma & health care
9.83 0.12(1.24%) NAV as on 11 Feb 2026
0.92 % 1 M
5.81 % 1 Y
NA 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.37

As on 31 Dec, 2025
age-icon Age :

1 yrs 2 m

Since 06 12 ,2024
exit_load Exit Load :

0.5%

aum AUM :

88.38 Crs

lock_in Lock-in :

0.50% on or before 90D, Nil after 90D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

7.91

Min_Investment Min. Investment :

SIP 1000 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Anandha Padmanabhan Anjeneyan,Utsav Mehta,Sharma Vivek

LATEST ASSET & PORTFOLIO ALLOCATION

as on Jan 31 ,2026
Others 2.22 %
Equity 97.78 %

TOP HOLDINGS

Sun Pharmaceutical Industries...11.31 %
Divi's Laboratories Ltd.10.32 %
Dr. Reddy's Laboratories Ltd.6.36 %
Aster DM Healthcare Ltd.6.24 %
JB Chemicals & Pharmaceuticals...6.09 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs60.10
Hospital & Healthcare Services23.75
Miscellaneous5.00
Chemicals2.98
Fintech2.26
See All Sectors

5-YEARS HISTORY

Financial Year2024-20252025-2026
NAV in Rs (as on 11-Feb-2026)9.379.83
Net Assets(Rs Crores) (as on 11-Feb-2026) 104.18 88.38
Scheme Returns(%)(Absolute)-6.306.50
B'mark Returns(%)(Absolute)NANA
Category Rank91/10280/115

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

PGIM India Healthcare Fund-Reg(G)Very HighEquity9.830.12(1.24%)NAV As on 11 Feb, 202606-Dec-2024Inception Date88.38AUM In Cr.5.81%1YNA%3YNA%5Y-1.44%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity38.530.18(0.47%)NAV As on 11 Feb, 202613-Jul-2018Inception Date6,658.41AUM In Cr.6.32%1Y26.74%3Y16.57%5Y19.45%Since Inception
Nippon India Pharma Fund(G)Very HighEquity509.704.98(0.99%)NAV As on 11 Feb, 202605-Jun-2004Inception Date7,875.40AUM In Cr.7.15%1Y22.44%3Y14.67%5Y19.86%Since Inception
corporate OFFICE Jhaveri Securities301/302 Payal Tower-II,Opp. M. S. University, Sayajigunj, Vadodara 390020.
CALL US 91-265-6161200/7161200
EMAIL US info@jhaveritrade.com
SEBI Reg. No. NSE, BSE, MCX : INZ000199232 Membership No.: NSE:08232, BSE:3015, MCX:56465 SEBI Regn.No. of DP : IN-DP-195-2016 (NSDL DPID:IN301991) AMFI: ARN-A3524 CIN of JSL: U67120GJ1992PLC018194 | GST : 24AAACJ4727A2Z4
COMPLIANCE OFFICER OFFICE
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors
© CopyRights 2022, Jhaveri Securities All rights reserved.
Designed & Developed by Accord Fintech Pvt Ltd.